Contract Service Directory

Clinsync Clinical Research Private Ltd.





Company Headquarters

#4-1-1, Hayathnagar.
Hyderabad, Andhra Pradesh 501505
India

Contract Service Directory

    Related Content

    • Breaking News | Facilities | Industry News | Inspections
      Frontida BioPharm Launches Expansion Efforts

      Frontida BioPharm Launches Expansion Efforts

      Comes on heels of receiving FDA clearance
      05.26.17

    • Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      Avista to Support Development of an Opioid Addiction Vaccine

      Avista to Support Development of an Opioid Addiction Vaccine

      Mfg. and dev. partnership with Minneapolis Medical Research Foundation to produce conjugate vaccine to combat substance abuse
      05.26.17

    • Promotions & Moves

      Akebia Therapeutics Names CMO

      Jain to lead clinical development of the company’s HIF pipeline
      05.25.17


    • Clinical Trials | CRO News | Information Technology
      CROS NT Expands Medidata Pact

      CROS NT Expands Medidata Pact

      Will offer customers Medidata’s next-gen EDC and RTSM systems
      05.23.17

    • Industry News
      Worldwide Clinical Trials Appoints Clinical Ops VP

      Worldwide Clinical Trials Appoints Clinical Ops VP

      Nowatkoski brings extensive senior clinical operations
      05.23.17

    • Clinical Trials | Drug Development | Information Technology | Regulatory Affairs

      Using Pragmatic Randomization in Real-World Studies

      How PCTs increase the robustness of real world studies at a fraction of the cost of classic randomized trials
      Nancy Dreyer, MPH, Ph.D. , Global Chief of Scientific Affairs and Senior Vice President, Real-World & Late Phase Research, QuintilesIMS 05.22.17


    • Clinical Trials | Drug Development

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Industry News
      Kemwell Provides Services for U.S. Trial

      Kemwell Provides Services for U.S. Trial

      Supplies biologics drug substance for phase 1 clinical trials for U.S. IND filing
      05.18.17